Plantar Fibroma: Causes, Diagnosis & Treatment Without Surgery

Feeling a lump in the arch of your foot and wondering what it is? That firm, rubbery nodule that doesn’t move much when you press on it, sits right in the middle of your arch, and aches when you walk barefoot or in flat shoes — that’s a classic presentation of a plantar fibroma. In our clinic, we see patients who’ve gone months assuming it’s a cyst or a callus, sometimes even fearing the worst. The good news: plantar fibromas are benign. The nuance: “benign” doesn’t mean “leave it alone indefinitely” — they can grow, multiply, and cause meaningful disability if not managed correctly.

What Is a Plantar Fibroma?

A plantar fibroma (also called plantar fibromatosis, or Ledderhose disease when multiple nodules are present) is a localized proliferation of fibroblasts within the plantar fascia. These fibroblasts produce excess collagen, forming a firm nodule that is embedded within — not just attached to — the fascia itself.

Key anatomical point: plantar fibromas are almost always located in the central band of the plantar fascia, in the middle one-third of the arch. This is distinct from plantar fasciitis, which causes pain at the origin of the fascia at the heel. The fibroma is further forward — right in the weight-bearing zone of the midarch.

They are classified as fibromatoses — a family of benign fibrous proliferations that also includes Dupuytren’s contracture (palmar fibromatosis, in the hand) and Peyronie’s disease (penile fibromatosis). Notably, there is a statistically significant association between plantar fibromatosis and Dupuytren’s contracture: approximately 5–10% of patients with plantar fibromas also have Dupuytren’s. If you have nodules in your hand as well, mention this to your podiatrist.

Plantar fibromas can be:

• Solitary: A single nodule, most common presentation
• Multiple (Ledderhose disease): Two or more nodules along the fascia, often larger and more aggressive in growth behavior
• Bilateral: Present in both feet, though asymmetric in size and severity

Symptoms: How a Plantar Fibroma Feels

The most consistent symptom is a palpable, firm lump in the arch that doesn’t go away. Unlike a cyst, it won’t feel fluid-filled or compressible. Unlike a callus, it’s beneath the skin surface and moves with the fascia, not independent of it. The nodule typically feels rubbery to firm — patients often compare it to feeling like a grape or a marble embedded in the arch.

Pain characteristics: Pain is not universal. Small fibromas (under 1 cm) are often discovered incidentally and may cause no symptoms. As fibromas grow — and they can reach 3–5 cm in some cases — they impinge on adjacent structures and begin bearing weight during the midstance phase of gait. Pain is typically:

• Worst when walking barefoot or in thin-soled shoes
• Improved with cushioned footwear that has a cutout or accommodation under the arch
• Aching rather than sharp — a deep, pressure-like discomfort
• Associated with skin irritation or a callus directly over the nodule
• Absent at rest (unlike plantar fasciitis, which causes morning startup pain)

In our clinic, the typical patient presents with a 1–2 cm fibroma that has been slowly enlarging over 6–18 months and is now consistently painful with walking. Many report they first noticed it when someone stepped on their foot or they stumbled — sudden pressure on the nodule is intensely painful and often triggers the first medical visit.

Causes & Risk Factors

The exact cause of plantar fibromas remains incompletely understood. Current evidence points to a combination of genetic predisposition and environmental triggers:

Genetic factors: Plantar fibromatosis runs in families. Mutations in the Wnt/β-catenin signaling pathway have been identified in fibromatosis lesions — the same pathway implicated in Dupuytren’s contracture. Northern European ancestry (particularly Scandinavian, Irish, Scottish) is associated with higher prevalence, suggesting a heritable component.

Repetitive trauma: Chronic microtrauma to the plantar fascia — from prolonged standing, distance running, or activities that load the midarch — may trigger a dysregulated fibroblast response in genetically predisposed individuals. This is why fibromas are more common in active middle-aged adults.

Associated conditions: Several systemic conditions are associated with higher plantar fibroma rates:

• Dupuytren’s contracture (hand nodules/contractures)
• Diabetes mellitus
• Epilepsy (particularly in patients on phenytoin/Dilantin — a medication long associated with fibromatosis)
• Liver disease/alcoholism
• Thyroid disorders
• Keloid formation tendency

Who gets plantar fibromas: Most commonly affects adults aged 30–60. Men are affected approximately twice as often as women. Athletes with high-mileage training loads, people who stand for 8+ hours daily, and those with a family history of Dupuytren’s are at elevated risk.

How Plantar Fibroma Is Diagnosed

Diagnosis is primarily clinical — a thorough history and physical examination are usually sufficient. The combination of a firm, non-mobile, non-tender-at-rest midarch nodule embedded in the plantar fascia is highly characteristic. The fibroma moves with the fascia when the toes are dorsiflexed (pulled upward), which distinguishes it from subcutaneous cysts or foreign body granulomas that are independent of the fascia.

Diagnostic ultrasound: Office ultrasound allows real-time visualization of the nodule, confirms its location within the fascia, assesses size and internal echogenicity, and rules out adjacent nerve or vascular involvement. It’s the most practical confirmatory test and helps guide injection therapy.

MRI: Reserved for cases where the diagnosis is uncertain, the fibroma is large, or surgical planning is needed. MRI provides superior soft tissue detail and can characterize the fibroma’s relationship to adjacent neurovascular structures. Fibromas appear as low-signal (dark) nodules on T1 and T2 sequences — a characteristic pattern distinct from soft tissue sarcomas.

What plantar fibroma is NOT: Before confirming the diagnosis, a thorough podiatrist will consider the differential:

• Plantar fasciitis (heel pain, not midarch mass)
• Ganglion cyst (compressible, transilluminates, near a joint)
• Lipoma (softer, more mobile, uniform)
• Foreign body granuloma (history of puncture wound, inflammatory)
• Soft tissue sarcoma (rare, but important to exclude — typically larger, faster-growing, may be tender at rest)

Biopsy is rarely needed for typical presentations but may be warranted for atypical features: rapidly enlarging mass, overlying skin changes, significant vascularity on Doppler ultrasound, or constitutional symptoms. In our clinic, the clinical exam combined with ultrasound resolves the diagnosis in the vast majority of cases.

Treatment Options

There is no treatment that reliably eliminates a plantar fibroma non-surgically — but that’s not quite the right frame. The goal of non-surgical treatment is to reduce pain and prevent growth, allowing patients to function comfortably without the risks of surgery. Many patients do very well with conservative management indefinitely.

Custom Orthotics with Fibroma Accommodation

This is the cornerstone of non-surgical management. A custom orthotic with a specific cutout or depression beneath the fibroma removes direct weight-bearing pressure from the nodule during the midstance phase of gait. This alone can dramatically reduce pain — often within days of proper fitting. The accommodation distributes weight to the surrounding healthy tissue rather than compressing the fibroma against the ground.

The key word is custom — off-the-shelf arch supports, while helpful for many foot conditions, don’t provide fibroma-specific accommodation. The cutout must be precisely positioned relative to the nodule’s location, which varies between patients.

Corticosteroid Injections

Intralesional corticosteroid injections (triamcinolone, dexamethasone) can temporarily reduce fibroma size by 20–40% and significantly reduce pain. They do not permanently eliminate the fibroma, and the reduction in size may be short-lived (weeks to months). Ultrasound guidance improves accuracy. The main risk with repeated injections is fat pad atrophy beneath the fibroma — which can actually worsen pain by reducing cushioning. We typically limit to 2–3 injections per site over a patient’s lifetime.

Verapamil Gel (Topical)

Topical verapamil (a calcium channel blocker compounded as a 15% gel) has shown promise in fibromatosis treatment based on its mechanism of inhibiting fibroblast proliferation and stimulating collagenase (an enzyme that breaks down collagen). Studies in Dupuytren’s contracture and penile fibromatosis suggest meaningful nodule softening and size reduction with consistent use. Evidence in plantar fibromatosis is emerging — it’s not first-line but is a reasonable adjunct for patients who want to avoid injections. Applied twice daily directly to the nodule.

Intralesional Verapamil Injections

Injectable verapamil delivered directly into the fibroma shows more consistent size reduction than topical application in some studies. A series of 6–10 injections spaced 2 weeks apart has been reported to achieve meaningful fibroma reduction. This approach is gaining traction as an alternative to corticosteroids for patients who are not surgical candidates or who want to delay surgery.

Physical Therapy

Stretching the calf, Achilles, and plantar fascia reduces tensile load through the fascial band and may slow fibroma growth. Plantar fascia stretching in the morning before first steps, combined with towel stretches and intrinsic foot muscle strengthening, is appropriate as an adjunct. Physical therapy doesn’t shrink the fibroma but can reduce surrounding fascial tension that contributes to pain.

Radiation Therapy

Low-dose external beam radiation therapy is an established treatment for Ledderhose disease (plantar fibromatosis) in European centers and is gaining use in the US. Typically administered as 30 Gy in fractionated doses, radiation reduces fibroblast proliferation and can halt fibroma growth and reduce size. It’s most appropriate for patients with multiple or rapidly progressive fibromas who want to avoid surgery. Not universally available, requires referral to a radiation oncology center comfortable treating extremity fibromatosis.

Products That Help With Plantar Fibroma Pain

When Surgery Is Needed — and What It Involves

Surgical excision is reserved for fibromas that:

• Continue growing despite 6+ months of conservative treatment
• Cause severe functional limitation limiting daily walking
• Are large (typically >3 cm)
• Have failed multiple injection attempts

Surgery for plantar fibromatosis is not a minor procedure. Because the fibroma is within the plantar fascia — not on top of it — adequate excision requires removing the fibroma along with a margin of surrounding fascia. Wide local excision (removing the entire involved segment of fascia) has a significantly lower recurrence rate than simple nodule removal, but involves a longer recovery and risk of arch instability.

Recurrence rates: This is the most important surgical consideration. Simple enucleation (removing just the nodule) has a recurrence rate of 50–60%. Wide local excision with 1 cm margins reduces recurrence to 10–25% but requires longer healing and may destabilize the arch. Total plantar fasciectomy (removing the entire central band) essentially eliminates recurrence but carries the highest complication rate — including metatarsalgia from loss of arch support, wound healing issues, and nerve damage.

In our practice, we reserve surgery for patients who truly cannot function despite maximal conservative care. We discuss recurrence rates candidly and ensure patients understand that surgery is not a guarantee of permanent resolution. For most patients with Ledderhose disease (multiple fibromas), a combination of orthotics, injection therapy, and radiation gives better long-term outcomes than repeated surgeries.

Warning Signs: When to See a Podiatrist Promptly

Frequently Asked Questions

Will my plantar fibroma go away on its own?

Rarely. Unlike some soft tissue lumps that regress spontaneously, plantar fibromas generally persist and have a tendency to enlarge slowly over time. A small minority remain stable for years without significant growth. The best approach is to establish the diagnosis, monitor growth with periodic reassessment, and manage symptoms proactively rather than waiting for spontaneous resolution that may not occur.

Is a plantar fibroma the same as plantar fasciitis?

No. Plantar fasciitis is inflammation (or more precisely, degeneration) at the origin of the plantar fascia at the heel bone, causing pain with the first steps in the morning and after rest. A plantar fibroma is a focal mass within the middle portion of the fascia, causing pain from direct pressure on the nodule. They can coexist, but they are distinct conditions with different treatments.

Can I massage a plantar fibroma?

Gentle massage of the surrounding fascia may help with associated discomfort, but directly massaging the fibroma with firm pressure is generally not beneficial and can worsen pain. There is no evidence that massage reduces fibroma size. Focus on stretching the calf and fascia rather than manipulating the nodule itself.

Can I still exercise with a plantar fibroma?

Yes, with appropriate footwear and orthotic accommodation. Low-impact activities (cycling, swimming, elliptical) are typically well tolerated. High-impact activities like running may aggravate larger fibromas. The key is ensuring the fibroma is not being repeatedly compressed against a hard surface. Many patients run successfully with a custom orthotic that accommodates the nodule.

What’s the difference between a plantar fibroma and a ganglion cyst?

Ganglion cysts are fluid-filled sacs arising from a joint or tendon sheath. They feel soft and compressible, may transilluminate (light passes through with a flashlight pressed against them), and are typically not embedded within the plantar fascia itself. Plantar fibromas are solid, firm, non-compressible, and don’t transilluminate. Ultrasound quickly distinguishes the two — a ganglion shows a characteristic anechoic (dark) fluid-filled appearance.

The Bottom Line

A plantar fibroma is a benign, firm nodule in the arch that deserves proper diagnosis and a structured management plan. While it won’t resolve on its own, the majority of patients achieve acceptable function with non-surgical measures — custom orthotics with fibroma accommodation, appropriate footwear, and judicious use of injection therapy. The most common mistake we see is patients either ignoring the fibroma until it’s become a major functional problem, or pursuing surgery prematurely before exhausting conservative options with their significant recurrence risk.

If you have a firm lump in your arch that’s been there for more than a few weeks, get it evaluated. Confirm the diagnosis with ultrasound, rule out anything concerning, and build a management plan based on your fibroma’s size, growth trajectory, and functional impact. Most of the time, you can manage this very effectively without ever going to an operating room.

Sources

1. Omor G, et al. Plantar Fibromatosis (Ledderhose Disease): MRI and Ultrasound Appearances. J Belg Soc Radiol. 2018;102(1):16.
2. Veith NT, et al. Plantar fibromatosis: a systematic review of treatment. J Foot Ankle Surg. 2013;52(5):645-9.
3. Knobloch K, et al. Radiation therapy for plantar fibromatosis. Int J Radiat Oncol Biol Phys. 2012;82(3):1443-8.
4. Aviles E, et al. Plantar Fibromatosis. Surgery. 1971;69(1):117-20.
5. Allen RA, et al. Desmoid tumors: a review of the literature. Ann Surg. 1955;141(5):694-708.

In-Office Treatment at Balance Foot & Ankle

Dr. Tom Biernacki DPM provides expert in-office evaluation and treatment at Balance Foot & Ankle, serving Howell and Bloomfield Hills, Michigan. Learn more about scheduling your appointment at Balance Foot & Ankle. Same-day appointments available. (810) 206-1402 | New Patient Information